Skip to main content

Table 2 Baseline characteristics of T2DM patients with and without overweight

From: Impact of overweight on left ventricular function in type 2 diabetes mellitus

  T2DM patients with overweight
(n = 70)
T2DM patients without overweight
(n = 75)
p value
Clinical data
 Age, years 59 ± 14 61 ± 13 0.31
 Female, n (%) 36 (51) 31 (41) 0.22
 Body mass index, kg/m2 30 ± 4 22 ± 2 < 0.05
 Heart rate, bpm 72 ± 13 70 ± 11 0.25
 DM duration, years 12 ± 8 10 ± 10 0.31
 Hypertension, n (%) 46 (66) 39 (53) 0.11
 Dyslipidemia, n (%) 55 (79) 35 (47) < 0.05
Blood exam and urinary test
 HbA1c, % 8.5 ± 1.6 8.7 ± 2.5 0.53
 Low-density lipoprotein, mg/dL 107 ± 31 110 ± 37 0.52
 Triglyceride, mg/dl 165 ± 75 138 ± 89 < 0.05
 eGFR, mL/min/1.73 m2 72 ± 24 77 ± 26 0.24
Medical treatment
 CCB, n (%) 33 (47) 15 (20) < 0.05
 ACEI/ARB, n (%) 41 (59) 30 (41) < 0.05
 β-Blocker, n (%) 7 (10) 6 (8) 0.78
 Statin, n (%) 44 (63) 25 (34) < 0.05
 Insulin, n (%) 41 (59) 32 (43) 0.07
 DPP-4I, n (%) 38 (54) 39 (53) 0.85
 GLP-1RA, n (%) 12 (17) 2 (2) < 0.05
 Sulfonylurea, n (%) 18 (26) 18 (24) 0.84
 α-GI, n (%) 12 (17) 17 (23) 0.36
 Thiazolidine, n (%) 10 (14) 4 (5) 0.09
 Metformin, n (%) 44 (63) 35 (47) 0.06
Echocardiography
 LV end systolic volume, mL 28 ± 10 25 ± 10 0.08
 LV end diastolic volume, mL 78 ± 21 72 ± 21 0.13
 LV ejection fraction, % 65 ± 5 66 ± 4 0.06
 Stroke volume, mL 64 ± 14 62 ± 11 0.34
 Left atrial volume index, mL/m2 31 ± 9 29 ± 8 0.08
 LV mass index, g/m2 84 ± 19 75 ± 21 < 0.05
 E/e′ 11.1 ± 4.0 10.3 ± 4.1 0.26
 e′ 5.8 ± 1.4 6.3 ± 1.8 0.06
 Global longitudinal strain, % 17.0 ± 2.4 18.9 ± 2.6 < 0.05
  1. Values are mean ± SD for normally distributed data and median and interquartile range for non-normally distributed data, or n (%)
  2. GFR estimated glomerular filtration rate, CCB calcium channel blocker, ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin II receptor blocker, DPP-4I dipeptidyl peptidase-4 inhibitor, GLP-1RA glucagon like peptide-1receptor agonist, α-GI α-glucosidase inhibitor. Other abbreviations as in Table 1